All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
EBNA3C is encoded by Epstein-Barr virus (EBV), which is one of the latent proteins. As a potent transcriptional coregulator that interacts with numerous cellular proteins, EBNA3C is essentially involved in regulating multiple important cellular pathways, including cell cycle and apoptosism. Therefore, EBNA3C is playing a critical role in EBV-induced growth transformation of primary B lymphocytes. EBNA3C is related to Burkitt's lymphoma (BL), nasopharyngeal carcinoma (NPC), and AIDS-associated lymphomas.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-MZ043 | Anti-EBNA3C (EBNA Clone 315) h(41BB-CD3ζ) CAR, pCDCAR1 | Virus | EBNA Clone 315 | Human | scFv-41BB-CD3ζ | Retroviral | NK cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION